ANUHPHR

Anuh Pharma LimitedNSE
₹95.53+5.24 (+5.80%)

Market Closed · NSE · INR

Open

₹92

High

₹99.5

Low

₹91.79

Prev Close

₹90.29

52-Week Range100% from low
₹67
₹95.53

Market Cap

₹904.92 Cr

Small Cap

P/E (TTM)

17.23

EPS

₹5.24

Div Yield

1.66%

P/B Ratio

2.72

ROE

14.9%

Key Metrics

Forward P/E-
Book Value₹35.14
Debt/Equity0.00×
Revenue Growth3.9%
Profit Margin5.43%
Operating Margin8.00%
Volume17.50 L
Avg Volume (20d)1.26 L
Delivery %35.62%
Trades15,255

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic...

anuhpharma.com323 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 3.00/share
25
26
05 Aug 20261.50
14 Aug 20251.50
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.